{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T18:05:05Z","timestamp":1775757905863,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.canrad.2021.12.006","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T05:46:06Z","timestamp":1646372766000},"page":"663-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1692-6142","authenticated-orcid":false,"given":"G.-S.","family":"Duo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-L.","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.-Y.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-5568","authenticated-orcid":false,"given":"L.-J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2021.12.006_bib0135","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/hed.21830","article-title":"Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data","volume":"34","author":"Turner","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.12.006_bib0140","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/00016480310001295","article-title":"Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000","volume":"123","author":"Theilgaard","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0145","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1470-2045(01)00558-7","article-title":"Esthesioneuroblastoma: a meta-analysis and review","volume":"2","author":"Dulguerov","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11912-018-0661-6","article-title":"Olfactory neuroblastoma","volume":"20","author":"Abdelmeguid","year":"2018","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.canrad.2021.12.006_bib0155","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/lary.25862","article-title":"Patterns of regional and distant metastasis in esthesioneuroblastoma","volume":"126","author":"Banuchi","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2021.12.006_bib0160","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1227\/00006123-199305000-00002","article-title":"Esthesioneuroblastoma: prognosis and management","volume":"32","author":"Morita","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canrad.2021.12.006_bib0165","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/0194599820915487","article-title":"Comparing kadish and modified dulguerov staging systems for olfactory neuroblastoma: an individual participant data meta-analysis","volume":"163","author":"Arnold","year":"2020","journal-title":"Otolaryngology"},{"key":"10.1016\/j.canrad.2021.12.006_bib0170","doi-asserted-by":"crossref","first-page":"774","DOI":"10.12998\/wjcc.v3.i9.774","article-title":"Esthesioneuroblastoma: multimodal management and review of literature","volume":"3","author":"Kumar","year":"2015","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.canrad.2021.12.006_bib0175","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.hoc.2012.08.005","article-title":"Esthesioneuroblastoma: a contemporary review of diagnosis and management","volume":"26","author":"Bak","year":"2012","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.canrad.2021.12.006_bib0180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hed.20127","article-title":"Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center","volume":"27","author":"Diaz","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.12.006_bib0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0030-6657(11)70715-6","article-title":"The results of combined treatment patients with olfactory neuroblastoma in material of Cancer Center in Warsaw","volume":"65","author":"Jarz\u0105bski","year":"2011","journal-title":"Otolaryngol Pol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0190","article-title":"Surgery as single-modality treatment for early-stage olfactory neuroblastoma: an institutional experience, systematic review and meta-analysis","author":"Meerwein","year":"2020","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.canrad.2021.12.006_bib0195","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/lary.26908","article-title":"Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb","volume":"128","author":"Mays","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.canrad.2021.12.006_bib0200","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/alr.22027","article-title":"Patient, disease, and treatment factors associated with overall survival in esthesioneuroblastoma","volume":"7","author":"Carey","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0205","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-6-41","article-title":"Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database","volume":"6","author":"Platek","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0210","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1186\/s12885-020-07435-7","article-title":"A novel nomogram to predict the overall survival in esthesinoeroblastoma","volume":"20","author":"Jiang","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2021.12.006_bib0215","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaoto.2014.2541","article-title":"Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis","volume":"140","author":"Tajudeen","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2021.12.006_bib0220","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archotol.133.3.276","article-title":"Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors","volume":"133","author":"Jethanamest","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.canrad.2021.12.006_bib0225","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7150\/jca.21605","article-title":"Exploration of the optimal treatment regimes for Esthesioneuroblastoma: a single center experience in China","volume":"9","author":"Yuan","year":"2018","journal-title":"J Cancer"},{"key":"10.1016\/j.canrad.2021.12.006_bib0230","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3389\/fonc.2020.01158","article-title":"Intensity-modulated radiation therapy for esthesioneuroblastoma: 10-year experience of a single institute","volume":"10","author":"Bao","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0235","doi-asserted-by":"crossref","first-page":"104618","DOI":"10.1016\/j.oraloncology.2020.104618","article-title":"Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma","volume":"103","author":"Song","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0240","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12885-017-3247-z","article-title":"Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients","volume":"17","author":"Xiong","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2021.12.006_bib0245","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1002\/hed.25209","article-title":"Esthesioneuroblastoma with distant metastases: systematic review & meta-analysis","volume":"40","author":"Marinelli","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.12.006_bib0250","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-008-9645-y","article-title":"Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma","volume":"90","author":"Porter","year":"2008","journal-title":"J Neurooncol"},{"key":"10.1016\/j.canrad.2021.12.006_bib0255","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hed.25558","article-title":"Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma","volume":"41","author":"Miller","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2021.12.006_bib0260","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/COC.0000000000000649","article-title":"Chemotherapy in esthesioneuroblastoma\/olfactory neuroblastoma: an analysis of the Surveillance Epidemiology and End Results (SEER) 1973\u20132015 database","volume":"43","author":"Cranmer","year":"2020","journal-title":"Am J Clin Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:34:49Z","timestamp":1761136489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822000361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1278321822000361"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2021.12.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-353943\/v1","asserted-by":"object"}]},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival impact of postoperative radiotherapy in patients with olfactory neuroblastoma: 513 cases from the SEER database","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}